Yarrow Bioscience, Inc. (YARW) AI Dilution Summary
Updated Oct 6, 2026
Cash was $22,925,000 at 2026-06-30 against estimated monthly burn of $1,012,167. The most recent raise is an underwritten public offering dated 2026-09-14: 5,769,231 shares at $26.00 plus 865,384 option shares, for an estimated $161,800,000 net. Separately, an ATM program with TD Securities (USA) LLC is authorised to $50,000,000, with $0 sold to date.